- Home
- SAGE vs PBT Comparison
SAGE vs PBT Comparison
Compare SAGE & PBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- PBT
- Stock Information
- Founded
- SAGE 2010
- PBT 1980
- Country
- SAGE United States
- PBT United States
- Employees
- SAGE N/A
- PBT N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- PBT Oil & Gas Production
- Sector
- SAGE Health Care
- PBT Energy
- Exchange
- SAGE Nasdaq
- PBT Nasdaq
- Market Cap
- SAGE 415.0M
- PBT 475.4M
- IPO Year
- SAGE 2014
- PBT N/A
- Fundamental
- Price
- SAGE $6.71
- PBT $9.77
- Analyst Decision
- SAGE Hold
- PBT
- Analyst Count
- SAGE 19
- PBT 0
- Target Price
- SAGE $9.88
- PBT N/A
- AVG Volume (30 Days)
- SAGE 934.8K
- PBT 80.5K
- Earning Date
- SAGE 04-29-2025
- PBT 01-01-0001
- Dividend Yield
- SAGE N/A
- PBT 4.25%
- EPS Growth
- SAGE N/A
- PBT N/A
- EPS
- SAGE N/A
- PBT 0.55
- Revenue
- SAGE $47,404,000.00
- PBT $27,114,144.00
- Revenue This Year
- SAGE $100.64
- PBT N/A
- Revenue Next Year
- SAGE $70.19
- PBT N/A
- P/E Ratio
- SAGE N/A
- PBT $17.75
- Revenue Growth
- SAGE N/A
- PBT N/A
- 52 Week Low
- SAGE $4.62
- PBT $8.01
- 52 Week High
- SAGE $14.56
- PBT $14.26
- Technical
- Relative Strength Index (RSI)
- SAGE 35.06
- PBT 49.04
- Support Level
- SAGE $7.23
- PBT $9.73
- Resistance Level
- SAGE $7.63
- PBT $10.20
- Average True Range (ATR)
- SAGE 0.29
- PBT 0.36
- MACD
- SAGE -0.09
- PBT 0.00
- Stochastic Oscillator
- SAGE 0.38
- PBT 48.19
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.